Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 67

Sort by

Sort Order Select

Journal Articles

Impact of Allogeneic Hematopoietic Cell Transplantation (allo-HCT) on the Outcomes of Angioimmunoblastic T-Cell Lymphoma (AITL): A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis

Narendranath Epperla, MD, Kwang Woo Ahn, PhD, Carlos Litovich, MPH, Mohamed A Kharfan-Dabaja, MD, Sonali M. Smith, MD, Anna Sureda, MD, Timothy S. Fenske, MD, Mehdi Hamadani, MD

Blood (2018) 132 (Supplement 1): 969.

https://doi.org/10.1182/blood-2018-99-110469

Published: 2018

Journal Articles

Impact of Depression or Anxiety on Opioid and Benzodiazepine Use in Hospitalized Hematopoietic Stem Cell Transplantation (HSCT) Recipients

Madiha Iqbal, MBBS, Aaron C. Spaulding, Chanel Wood, Salman Ahmed, MD, Prachi Jani, MD, Rami Manochakian, MD, Aneel Paulus, MD, Mohamed A Kharfan-Dabaja, MD, Ernesto Ayala, MD, Sikander Ailawadhi, Asher A. Chanan-Khan, MD, Shehzad Niazi, Taimur Sher, MD

Blood (2018) 132 (Supplement 1): 4852.

https://doi.org/10.1182/blood-2018-99-119912

Published: 2018

Journal Articles

Opiate and Benzodiazepine Use during Hospitalization for Hematopoietic Stem Cell Transplantation (HSCT) Is Associated with Adverse Health Related Outcomes

Madiha Iqbal, MBBS, Aaron C. Spaulding, Salman Ahmed, MD, Prachi Jani, MD, Chanel Wood, Shehzad Niazi, Rami Manochakian, MD, Aneel Paulus, MD, Ernesto Ayala, MD, Mohamed A Kharfan-Dabaja, MD, Vivek Roy, MD, Asher A. Chanan-Khan, MD, Sikander Ailawadhi, Taimur Sher, MD

Blood (2018) 132 (Supplement 1): 5873.

https://doi.org/10.1182/blood-2018-99-119781

Published: 2018

Journal Articles

Long-Term Follow up of Front-Line Therapy with Ofatumumab, High Dose Methylprednisolone and Lenalidomide (HiLO trial) for Treatment-Naïve Chronic Lymphocytic Leukemia

Ariel Felipe Grajales-Cruz, MD, Julio C. Chavez, MD, Elyce P. Turba, MSN, RN, Lisa Nodzon, PhD ARNP, AOCNP, Francisco Perez Leal, MD, Jose Sandoval-Sus, MD, Rami S. Komrokji, MD, Frederick L. Locke, MD, Mohamed A Kharfan-Dabaja, MD, Bijal D. Shah, MD, Lubomir Sokol, MD PhD, Celeste M. Bello, MD, Javier Pinilla Ibarz, MD

Blood (2018) 132 (Supplement 1): 3150.

https://doi.org/10.1182/blood-2018-99-111564

Published: 2018

Journal Articles

Conditional Long-Term Survival Among Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Autologous Hematopoietic Cell Transplantation (AHCT)

Jessica ElAsmar, MD, Lisa Rybicki, MS, Brian J. Bolwell, MD, Mohamed A Kharfan-Dabaja, MD, Robert M. Dean, MD, Betty K. Hamilton, MD, Rabi Hanna, MD, Deepa Jagadeesh, MDMPH, Matt Kalaycio, MD, Hien D. Liu, MD, Brad Pohlman, MD, Ronald Sobecks, MD, Brian T. Hill, MD PhD, Navneet S. Majhail, MD MS

Blood (2017) 130 (Supplement 1): 3437.

https://doi.org/10.1182/blood.V130.Suppl_1.3437.3437

Published: 2017

Journal Articles

A Phase II Trial Evaluating the Use of the Histone Deacetylase Inhibitor Panobinostat for Graft-Versus-Host Disease (GVHD) Prevention

Lia Perez, MD, Hugo F. Fernandez, MD, Farhad Khimani, MBBS, Ernesto Ayala, MD, Mohamed A Kharfan-Dabaja, MD, Asmita Mishra, MD, Leonel Ochoa, MD, Brian C. Betts, MD, Joseph Pidala, MD PhD, Claudio Anasetti, MD

Blood (2017) 130 (Supplement 1): 1985.

https://doi.org/10.1182/blood.V130.Suppl_1.1985.1985

Published: 2017

Journal Articles

Adoptive Cellular Therapy with Donor Lymphocyte Infusion Versus a Second Allogeneic Hematopoietic Cell Transplant for Post-Allograft Relapsed Acute Myeloid Leukemia: An Intent-to-Treat Analysis on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Mohamed A Kharfan-Dabaja, MD, Myriam Labopin, MD, Emmanuelle Polge, Taiga Nishihori, MD, Ali Bazarbachi, MD PhD, Jürgen Finke, MD, Michael Stadler, MD PhD, Gerhard Ehninger, Bruno Lioure, MD, Nicolaas Schaap, Boris V Afanasyev, MD PhD Professor, Moshe Yeshurun, Cecilia Isaksson, Johan Maertens, Yves Chalandon, MD PhD, Christoph Schmid, Arnon Nagler, MD, Mohamad Mohty, MD PhD

Blood (2017) 130 (Supplement 1): 273.

https://doi.org/10.1182/blood.V130.Suppl_1.273.273

Published: 2017

Journal Articles

Feasibility and Efficacy of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation for HIV-Related Lymphoma: A Single-Institution Experience

Elsa Sleiman, MD, Alexandra Gomez, MD, Julio C. Chavez, MD, Mohamed A Kharfan-Dabaja, MD, Ernesto Ayala, MD

Blood (2016) 128 (22): 5823.

https://doi.org/10.1182/blood.V128.22.5823.5823

Published: 2016

Journal Articles

Incidence of Cytomegalovirus (CMV) Reactivation after Autologous Peripheral Blood Stem Cell Transplantation (ASCT) in 324 Patients with Multiple Myeloma and Lymphoma: A Single-Center Study at the American University of Beirut Medical Center (AUBMC)

Radwan Massoud, MD, Rita Assi, MD, Elie Fares, Nabila Kreidieh, Rami Mahfouz, Souha Kanj, Aline El-Zakhem, Mohamed A. Kharfan-Dabaja, MD, Ali Bazarbachi, MD PhD, Jean El Cheikh, MD PhD

Blood (2016) 128 (22): 5824.

https://doi.org/10.1182/blood.V128.22.5824.5824

Published: 2016

Journal Articles

Azacitidine As Post-Allograft Maintenance Helps Reduce Relapse Risk in High-Risk MDS and AML

Jean El Cheikh, MD PhD, Radwan Massoud, Elie Fares, Nabila Kreidieh, Rami Mahfouz, Mohamed A Kharfan-Dabaja, MD, Ali Bazarbachi, MD PhD

Blood (2016) 128 (22): 5872.

https://doi.org/10.1182/blood.V128.22.5872.5872

Published: 2016

Journal Articles

Fludarabine-Based Reduced Intensity Regimen for Matched Related Donor Stem Cell Transplantation in Acquired Severe Aplastic Anemia

Khaled M Ghanem, MD, Mohamed A. Kharfan-Dabaja, MD, Hassan El-Solh, MD, Nariman Harris, Nabila Kreidieh, Rita Nehme, Samar A. Muwakkit, MD, Raya Saab, MD, Ali Bazarbachi, MD PhD, Miguel R Abboud, MD

Blood (2016) 128 (22): 5753.

https://doi.org/10.1182/blood.V128.22.5753.5753

Published: 2016

Journal Articles

Impact of Serum Albumin in the Prognosis of Myc-Positive Aggressive B-Cell Lymphomas: Potential for a Novel Prognostic Score

Chetasi Talati, MD, Andrew Kuykendall, MD, Jori Kaplan, MD, Jose D Sandoval-Sus, MD, Samir Dalia, MD, Bijal D. Shah, MD, Celeste M. Bello, MD, Farhad Khimani, MD, Paul A. Chervenick, MD, Ernesto Ayala, MD, Frederick L. Locke, MD, Mohamed A Kharfan-Dabaja, MD, Eduardo M. Sotomayor, MD, Lubomir Sokol, Julio C. Chavez, MD

Blood (2016) 128 (22): 1870.

https://doi.org/10.1182/blood.V128.22.1870.1870

Published: 2016

Journal Articles

Bendamustine Demonstrates Promising Activity in Post-Brentuximab Failure Hodgkin Lymphoma Patients Who Had Also Failed a Prior Autologous HCT and Facilitates Successful Bridging to Allogeneic HCT

Jean Elcheikh, MD, Radwan Massoud, MD, Elie Fares, Mohamed A Kharfan-Dabaja, MD, Jisr Tamima, MD, Anas Mougharbel, MD, Ali Bazarbachi, MD PhD, Ahmad Ibrahim

Blood (2016) 128 (22): 5359.

https://doi.org/10.1182/blood.V128.22.5359.5359

Published: 2016

Journal Articles

Mutational Landscape of Chronic Lymphocytic Leukemia Using Next Generation Sequencing Technologies in the Real World Clinical Setting

Jose D Sandoval-Sus, MD, Facundo E. Stingo, MD, Todd C. Knepper, PharmD, Lisa Nodzon, PhDANP, Eric Padron, MD, Mohamed A Kharfan-Dabaja, MD, Julio C. Chavez, MD, Javier Pinilla-Ibarz, MD PhD

Blood (2016) 128 (22): 4366.

https://doi.org/10.1182/blood.V128.22.4366.4366

Published: 2016

Journal Articles

Fludarabine and Melphalan Results in Fewer Relapses Compared to Fludarabine and Targeted Busulfan in Patients Receiving Reduced Intensity Conditioning for AML and MDS

Ryan James Caddell, PharmD, Braydon Schaible, MPH, Zhenjun Ma, PhD, Elizabeth Dimaggio, PharmD, BCOP, Rebecca Tombleson, PharmD, BCOP, Claudio Anasetti, MD, Ernesto Ayala, MD, Brian C. Betts, MD, Mohamed A. Kharfan-Dabaja, MD, Frederick L. Locke, MD, Taiga Nishihori, MD, Joseph A. Pidala, MD, Hugo F. Fernandez, MD, Asmita Mishra, MD

Blood (2016) 128 (22): 3486.

https://doi.org/10.1182/blood.V128.22.3486.3486

Published: 2016

Journal Articles

Reduced-Intensity or Myeloablative Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: A Side-By-Side Systematic Review/Meta-Analysis

Maya Khalil, MD, Tea Reljic, MPH, Jessica El-Asmar, MD, Mehdi Hamadani, MD, Taiga Nishihori, MD, Ernesto Ayala, MD, Ambuj Kumar, MD MPH, Mohamed A Kharfan-Dabaja, MD

Blood (2016) 128 (22): 3551.

https://doi.org/10.1182/blood.V128.22.3551.3551

Published: 2016

Journal Articles

Myeloablative or Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Mantle Cell Lymphoma? a Systematic Review and Meta-Analysis

Mohamed A. Kharfan-Dabaja, MD, Tea Reljic, MPH, Jessica El-Asmar, MD, Taiga Nishihori, MD, Ernesto Ayala, MD, Mehdi Hamadani, MD, Ambuj Kumar, MD, MPH

Blood (2015) 126 (23): 2097.

https://doi.org/10.1182/blood.V126.23.2097.2097

Published: 2015

Journal Articles

Impact of Splenomegaly in the Presence of Negative PET FDG Avidity on Allogeneic Hematopoietic Cell Transplant Outcomes in Patients with Lymphoid Malignancies

Farhad Khimani, MD, Daniel K. Jeong, MD, Taiga Nishihori, MD, Ernesto Ayala, MD, Joseph A Pidala, MD, PhD, Frederick L. Locke, MD, Gage Kenneth, Julio C. Chavez, MD, Claudio Anasetti, MD, Mohamed A. Kharfan-Dabaja, MD

Blood (2015) 126 (23): 5524.

https://doi.org/10.1182/blood.V126.23.5524.5524

Published: 2015

Journal Articles

Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Peripheral T-Cell Lymphomas As Front-Line Consolidation or in the Relapsed/Refractory Setting: A Meta-Analysis

Jessica El-Asmar, MD, Tea Reljic, MPH, Ernesto Ayala, MD, Taiga Nishihori, MD, Mehdi Hamadani, MD, Ambuj Kumar, MD, MPH, Mohamed A. Kharfan-Dabaja, MD

Blood (2015) 126 (23): 4493.

https://doi.org/10.1182/blood.V126.23.4493.4493

Published: 2015

Journal Articles

An International Multicenter Comparative Analysis of Tacrolimus Plus Sirolimus with or without Antithymocyte Globulin As Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Allogeneic Hematopoietic Cell Transplantation

Mohamed A. Kharfan-Dabaja, MD, Rocio Parody, MD, Janelle Perkins, PharmD, Oriana Lopez-Godino, MD, Lucia Lopez-Corral, MD, Lourdes Vazquez, MD, Dolores Caballero, MD, Jose Falantes, MD, Jamie Shapiro, PharmD, Guillermo Orti, MD, Pere Barba, MD, David Valcárcel, MD PhD, Alber Esquirol, MD, Rodrigo Martino, MD PhD, Jose Luis Piñana, MD, Carlos Solano, MD, Joseph A Pidala, MD, PhD, Claudio Anasetti, MD, Jose A. Perez-Simon, MD, PhD

Blood (2015) 126 (23): 3142.

https://doi.org/10.1182/blood.V126.23.3142.3142

Published: 2015

NARROW

Impact of Allogeneic Hematopoietic Cell Transplantation (allo-HCT) on the Outcomes of Angioimmunoblastic T-Cell Lymphoma (AITL): A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis

Impact of Depression or Anxiety on Opioid and Benzodiazepine Use in Hospitalized Hematopoietic Stem Cell Transplantation (HSCT) Recipients

Opiate and Benzodiazepine Use during Hospitalization for Hematopoietic Stem Cell Transplantation (HSCT) Is Associated with Adverse Health Related Outcomes

Long-Term Follow up of Front-Line Therapy with Ofatumumab, High Dose Methylprednisolone and Lenalidomide (HiLO trial) for Treatment-Naïve Chronic Lymphocytic Leukemia

Conditional Long-Term Survival Among Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Autologous Hematopoietic Cell Transplantation (AHCT)

A Phase II Trial Evaluating the Use of the Histone Deacetylase Inhibitor Panobinostat for Graft-Versus-Host Disease (GVHD) Prevention

Feasibility and Efficacy of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation for HIV-Related Lymphoma: A Single-Institution Experience

Incidence of Cytomegalovirus (CMV) Reactivation after Autologous Peripheral Blood Stem Cell Transplantation (ASCT) in 324 Patients with Multiple Myeloma and Lymphoma: A Single-Center Study at the American University of Beirut Medical Center (AUBMC)

Azacitidine As Post-Allograft Maintenance Helps Reduce Relapse Risk in High-Risk MDS and AML

Fludarabine-Based Reduced Intensity Regimen for Matched Related Donor Stem Cell Transplantation in Acquired Severe Aplastic Anemia

Impact of Serum Albumin in the Prognosis of Myc-Positive Aggressive B-Cell Lymphomas: Potential for a Novel Prognostic Score

Bendamustine Demonstrates Promising Activity in Post-Brentuximab Failure Hodgkin Lymphoma Patients Who Had Also Failed a Prior Autologous HCT and Facilitates Successful Bridging to Allogeneic HCT

Mutational Landscape of Chronic Lymphocytic Leukemia Using Next Generation Sequencing Technologies in the Real World Clinical Setting

Fludarabine and Melphalan Results in Fewer Relapses Compared to Fludarabine and Targeted Busulfan in Patients Receiving Reduced Intensity Conditioning for AML and MDS

Reduced-Intensity or Myeloablative Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: A Side-By-Side Systematic Review/Meta-Analysis

Myeloablative or Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Mantle Cell Lymphoma? a Systematic Review and Meta-Analysis

Impact of Splenomegaly in the Presence of Negative PET FDG Avidity on Allogeneic Hematopoietic Cell Transplant Outcomes in Patients with Lymphoid Malignancies

Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Peripheral T-Cell Lymphomas As Front-Line Consolidation or in the Relapsed/Refractory Setting: A Meta-Analysis

An International Multicenter Comparative Analysis of Tacrolimus Plus Sirolimus with or without Antithymocyte Globulin As Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Allogeneic Hematopoietic Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only